Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR) granted an inducement restricted stock unit (RSU) award covering 3,500 shares of common stock on July 13, 2026 under its Equity Inducement Plan. The award was made to a newly hired employee as a material inducement to join the company and was approved by the compensation committee in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest and be settled on the third anniversary of the grant date, subject to continued employment, and are governed by an award agreement and the Inducement Plan.

News Market Reaction – LFCR

+1.85%

3 alerts

+1.85% Session close to close

+10.2% Peak Tracked

$173.67M Market Cap

0.3x Rel. Volume

In the Jul 16 session, LFCR gained 1.85%, reflecting a mild positive market reaction. Argus tracked a peak move of +10.2% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Placed against Lifecore’s low short-interest profile and an active S-3 resale shelf filed in 2025, t...

Analysis

Placed against Lifecore’s low short-interest profile and an active S-3 resale shelf filed in 2025, this inducement RSU grant looks like routine hiring-related equity compensation. Investors may instead focus on funding the $52.1 million preferred redemption obligation in late 2026.

Key Figures

Restricted stock units: 3,500 shares

1 metrics

Restricted stock units 3,500 shares Inducement RSU grant to a newly hired employee under Inducement Plan

Historical Context

5 past events · Latest: Jun 15 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 15	Customer agreement	Positive	-2.7%	Signed tech transfer and commercial manufacturing deal for neurological disorder product.
Jun 02	Customer agreement	Positive	+12.4%	New manufacturing services agreement for next-generation injectable ophthalmic product.
May 21	Conference participation	Neutral	+9.0%	Management attending William Blair Growth Stock Conference and investor meetings.
May 06	Q1 2026 earnings	Neutral	-3.9%	Reported Q1 2026 results and reaffirmed full-year revenue and EBITDA guidance.
Apr 29	Earnings date notice	Neutral	+2.6%	Scheduled Q1 2026 earnings release and webcast details for May 6, 2026.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has produced both double-digit gains and declines, suggesting no consistent reaction pattern yet.

Key Terms

restricted stock unit, equity inducement plan, nasdaq listing rule 5635(c)(4)

3 terms

restricted stock unit financial

"Lifecore granted a restricted stock unit (“RSU”) award with respect to 3,500 shares"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

equity inducement plan financial

"under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”)"

An equity inducement plan is a program that gives new hires or targeted employees stock, restricted shares, or stock options as a hiring or retention reward, often separate from the company’s regular long-term incentive plans. Think of it as a signing bonus paid in company stock: it helps attract and keep talent but matters to investors because it can dilute existing shares, change executive incentives, and affect future earnings through compensation expense.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4) under the Inducement Plan"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHASKA, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that effective on July 13, 2026, Lifecore granted a restricted stock unit (“RSU”) award with respect to 3,500 shares of its common stock under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”) to a newly hired employee of Lifecore.

The RSU award was granted pursuant to the offer letter between Lifecore and the employee, and as a material inducement to the employee joining Lifecore. The RSU award was approved by Lifecore’s compensation committee and was granted as an inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4) under the Inducement Plan.

The RSUs will vest and be settled on the third anniversary of the grant date, subject to continued employment. The RSU award is governed by an award agreement and the Inducement Plan.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Jennifer Arcure (Media)
917-603-0681
jarcure@vidasp.com

Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com

FAQ

What inducement equity award did Lifecore Biomedical (NASDAQ: LFCR) grant in July 2026?

Lifecore Biomedical granted an inducement RSU award for 3,500 shares of common stock. According to Lifecore, the award was issued under its Equity Inducement Plan as a material inducement for a newly hired employee to join the company.

When do the RSUs from Lifecore Biomedical's July 13, 2026 LFCR inducement grant vest?

The RSUs from Lifecore’s July 13, 2026 grant vest on the third anniversary of the grant date. According to Lifecore, vesting and settlement are subject to the employee’s continued employment through that vesting date.

Under which plan was Lifecore Biomedical's July 2026 LFCR inducement RSU grant issued?

The July 2026 inducement RSU grant was issued under Lifecore’s Equity Inducement Plan, as amended. According to Lifecore, the plan governs the award alongside a specific award agreement, consistent with Nasdaq Listing Rule 5635(c)(4).

Why did Lifecore Biomedical grant a 3,500-share RSU award to a new employee in 2026?

Lifecore granted the 3,500-share RSU award as a material inducement for the employee to join the company. According to Lifecore, the grant was made pursuant to the employee’s offer letter and approved by the compensation committee.

How does Nasdaq Listing Rule 5635(c)(4) relate to Lifecore Biomedical's July 2026 LFCR RSU grant?

Lifecore’s July 2026 RSU grant was structured as an inducement award under Nasdaq Listing Rule 5635(c)(4). According to Lifecore, this rule allows equity awards to new employees outside shareholder-approved plans when used as a material hiring inducement.

Who approved Lifecore Biomedical's July 13, 2026 inducement RSU grant for LFCR shares?

Lifecore’s compensation committee approved the July 13, 2026 inducement RSU grant. According to Lifecore, the committee authorized the award as an inducement equity grant under the company’s Equity Inducement Plan and Nasdaq Listing Rule 5635(c)(4).